Bulletin from Extraordinary General Meeting in Karessa Pharma Holding AB (publ) on the 3rd of March 2017

At the Extraordinary General Meeting of Karessa Pharma Holding AB (publ) on March 3rd 2017, Ulf Lindberg was elected to the Board of Directors as new Chairman of the Board and Michael Brobjer was elected as new Board member. Michael Brobjer also takes over as CEO.Ulf LindbergUlf Lindberg (born 1952) has more than 15 years’ experience from the pharmaceutical industry. For 7 years he was responsible for sales and marketing roles at the American company Lederle, and also for clinical research. Thereafter, Pharmacia for 8 years as Head of Marketing in Scandinavia, Director Business Area